Cargando…
Economic burden of severe asthma treatment: A real-life study()
BACKGROUND: Individuals with severe asthma represent 5%–10% of the general asthmatic population. Despite the use of biologic drugs during clinical management, inadequate control of the disease has translated into high economic impact. In Mexico, however, these costs have not yet been assessed. METHO...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260620/ https://www.ncbi.nlm.nih.gov/pubmed/35833203 http://dx.doi.org/10.1016/j.waojou.2022.100662 |